Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

Different immunohistochemical (IHC) assays were approved for PD-L1 expression examination on tumor cells in qualification to immune-checkpoint inhibitors therapy in NSCLC patients. These assays have some similarities, but also very serious differences. We assessed 2 IHC tests for PD-L1 expression ev...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncotarget 2017-09, Vol.8 (38), p.64283-64293
Hauptverfasser:	Krawczyk, Paweł, Jarosz, Bożena, Kucharczyk, Tomasz, Grenda, Anna, Reszka, Katarzyna, Pankowski, Juliusz, Wojas-Krawczyk, Kamila, Nicoś, Marcin, Szumiło, Justyna, Trojanowski, Tomasz, Milanowski, Janusz
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!